ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620674 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620674; 2) Community: the network communities that were significantly associated with the response to NSC 620674; 3) Molecule: the relationships between components within communities and NSC 620674; 4) MDR: the compounds that were significantly associated with the NSC 620674.

NSC Compound Enrichment Correlation
NSC 682995 5,8-Quinolinedione, 2-methyl- 0.0355196177493897 -0.38756291
NSC 702129 Null 0.0355196177493897 0.45761532
NSC 708806 Null 0.0355196177493897 -0.14602319
NSC 715648 Null 0.0355196177493897 0.45430572
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.0355196177493897 0.44643905
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.03551961774939 -0.18593834
NSC 645566 Null 0.03551961774939 0.049469868
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.03551961774939 -0.19168645
NSC 681239 Bortezomib 0.03551961774939 -0.02422819
NSC 701378 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- 0.03551961774939 -0.085224171
Total:53  Current:38    [First] [Prev] [Next] [Last]